Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Intestinal Barrier Function

Research synthesisVery low evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects on intestinal barrier function, with effect sizes predominantly moderate. The evidence is drawn entirely from reviews and animal/cell studies, with no human trial data available. No consistent dose, form, or population could be identified due to insufficient reporting.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. None of the 5 studies reported statistically significant findings, and all are non-human (reviews, animal, or cell models) — real-world human effects remain unconfirmed.

Generated Jul 11, 2026
8 of 8 papers
Back to top